via CDC – James Archer
University of Liverpool researchers, working with F2G Limited (Eccles, Manchester), have developed a new antifungal drug to help in the treatment of life threatening invasive fungal infections such as invasive aspergillosis.
Invasive fungal infections are common and often lethal. Despite optimal medical care mortality is 20-30% at six weeks and dramatically rises to 80-100% for drug resistant infection.
These infections occur most commonly in the context of leukemia and bone marrow transplantation and often in young patients with otherwise curable disease.
Orotomides
The researchers, led by Professor William Hope from the University’s Antimicrobial Pharmacodynamics and Therapeutics (APT) Group, have characterised the biochemical and physiologic effects (pharmacodynamics) of F901318, which is the lead compound of the new class of drugs termed the ‘orotomides’.
The ‘orotomides’, discovered by F2G Limited, have a novel mechanism of action which is the specific biochemical interaction through which a drug substance produces its pharmacological effect.
This is the first new class of antifungal agent to be discovered in the last three decades.
The study, which was supported by a research grant by F2G, has been published in mBio.
Clinical studies
APT’s work provides the underpinning evidence for efficacy and dosage justification for the very first patients receiving the new drug. Such information is required by regulatory agencies such as the European Medicines Agency and the Food and Drug Administration before clinical studies can proceed.
Professor Hope, said: “Antifungal resistance represents a major global clinical challenge. This study provides the necessary information to enable F901318 to be developed for clinical use.”
Learn more: Researchers help develop new antifungal drug
The Latest on: Antifungal drug
[google_news title=”” keyword=”antifungal drug” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
- Anidulafungin Market 2023 Industry Size, Share, Trends, Opportunities, Growth Analysis and Forecast to 2028on February 7, 2023 at 8:34 pm
Feb 08, 2023 (The Expresswire) -- "Anidulafungin Market" Size, Share and Trends Analysis Report 2023 - By Applications (Hospital, Drug store), By Types ...
- Repurposed UTI drug can treat deadly brain-eating amoebaon February 7, 2023 at 5:09 am
A decade-old medicine for urinary tract infections (UTIs) may effectively treat a rare brain infection caused by a rare brain-eating amoeba ...
- Antifungal Drugs Market Expected to Grow US$ 13,997.4 Million by 2028on February 2, 2023 at 10:03 am
The Insight Partners Latest Research for Report "Antifungal Drugs Market Forecast to 2028" Focuses Global Analysis by Infection Type (Superficial Fungal ...
- UGA researchers develop vaccine against invasive fungal infectionson February 1, 2023 at 1:11 am
The experimental vaccine is designed to protect against the most common pathogens that are responsible for more than 80% of fatal fungal infections.
- Antifungal Topical Drugs Market Size, Latest Trends, Share, Top Players, Revenue and Forecast 2028on January 31, 2023 at 9:42 pm
There are huge growth opportunities for the antifungal drug market due to ongoing public-private partnerships in the pharmaceutical sector. There are two types of antifungal drugs on the market: ...
- New vaccine targets life-threatening fungal infections, a growing health concernon January 31, 2023 at 9:35 pm
A new vaccine could be the first clinically approved immunization to protect against invasive fungal infections, a growing concern as antifungal drug resistance increases. Fungal infections cause ...
- Office on Drugs and Crimeon January 31, 2023 at 4:00 pm
UNODC’s mission is to contribute to global peace and security, human rights and development by making the world safer from drugs, crime, corruption and terrorism. This Strategy for the next five years ...
- Life-threatening fungal infections target of novel vaccine: Researchon January 31, 2023 at 10:01 am
A new vaccine from the University of Georgia could be the first clinically approved immunization to protect against invasive fungal infections, a growing concern as antifungal drug resistance ...
- New vaccine targets life-threatening fungal infectionson January 31, 2023 at 9:11 am
A new vaccine from the University of Georgia could be the first clinically approved immunization to protect against invasive fungal infections, a growing concern as antifungal drug resistance ...
- Fungi’s Drug-resistance Explained In Researchon January 30, 2023 at 2:43 am
Researchers are investigating how disease-causing fungi become resistant to antifungal drugs to help prevent potentially devastating consequences of the growing resistance harmful microbes are ...
via Google News and Bing News
